A man who had used opioids every day for years lay still inside an MRI scanner in Haifa. For about twenty minutes, a beam of sound waves was aimed at a structure deep in his brain roughly the size of an almond. When he came out, he rated his craving at zero out of ten. A week later his drug screen came back clean, and the three-pack-a-day cigarette habit he had carried for most of his adult life had dropped to a few smokes a day. He had not white-knuckled his way through withdrawal, and he had not failed and started over the way so many people do. A sound wave had quieted the part of his brain that was driving him.
That case, reported in late June 2026 from Rambam Health Care Campus, is dramatic enough to deserve some healthy suspicion. One patient is not a clinical trial. But it lands on top of a published study that is harder to wave away, and together they point at something I have argued for a long time: craving is a physical event in brain tissue, and physical events can be changed.
What the Sound Wave Actually Does
The target in both the Haifa case and the published work is the nucleus accumbens, the hub at the center of the brain's reward system. It is the structure that fires when you eat after being hungry, when you finish hard work, when someone you love walks into the room. Drugs hijack that same circuit and crank it far past anything ordinary life produces. Over months and years the circuit rewires around the drug, and the result is the relentless pull that patients describe as craving.
The new tool is low-intensity focused ultrasound. It is worth being precise about what that means, because focused ultrasound already has a reputation from a different use. In essential tremor and Parkinson's tremor, surgeons use high-intensity ultrasound to heat and destroy a tiny patch of tissue. That is not what is happening here. Low-intensity focused ultrasound does not burn anything. Guided by MRI, it delivers a gentle mechanical pulse to a millimeter-scale target and nudges that circuit's activity up or down without cutting, implanting, or removing a thing.
The numbers come from a trial published in Biological Psychiatry. Researchers enrolled eight people with severe opioid use disorder and gave each a single twenty-minute session aimed at both sides of the nucleus accumbens, then followed them for ninety days. Cue-induced craving, the spike you get when you see the paraphernalia or walk past the old spot, fell from a median of 6.9 before treatment to 0.6 three months later. The mean reduction was 91 percent. No serious device-related adverse events showed up on exams or imaging. And in the participants who got a higher dose, the daily pull toward nicotine eased along with the opioid craving.
Craving Lives in Circuitry, Not in Character
For thirty years I have watched people get told, in a hundred polite and impolite ways, that their addiction was a question of wanting it badly enough. The man in Haifa wanted to quit for years. Three packs a day did not survive twenty minutes of changing what his accumbens was doing. Willpower did not produce that result, and the absence of willpower was never the problem.
This is the same argument I made when I wrote that addiction is brain failure, not moral failure. The accumbens is older and faster than the parts of the brain we use to make resolutions. When that circuit is screaming, deliberation loses, and it loses every time, not because the person is weak but because that is how the wiring is built to work. A treatment that turns the volume down on the circuit itself is, in a sense, the most honest response we have produced to what addiction actually is.
It also helps explain a strange detail in the Haifa case. The man's craving for cigarettes and alcohol fell alongside his craving for opioids, even though the treatment was aimed at his opioid use. That convergence is not a fluke. Different substances ride into the brain through different doors, but they all end up pulling on the same reward hub. This is close to what George Koob and Kenneth Blum described decades ago as reward deficiency syndrome, the idea that a single under-responsive reward system sits underneath many compulsions at once. Touch the hub, and you touch everything plugged into it.
What This Does Not Mean Yet
The size of this matters, because false hope is its own kind of harm. Eight people is a feasibility trial, not a standard of care. The Haifa report is a single case. Low-intensity focused ultrasound is not FDA-approved for addiction, and no one should be calling clinics expecting to book it next week. The honest scientific posture is real interest paired with patience.
There is a deeper caution too. Cutting craving is not the same as building a recovered life. The pull toward the drug is what makes the first months brutal, and quieting it would be a genuine mercy. But the work of repairing relationships, rebuilding a daily structure, treating the depression or trauma that often sits underneath, and giving the dopamine system the long runway it needs does not disappear because a craving score drops. PET imaging shows that dopamine function takes twelve to seventeen months of abstinence to recover, not twenty minutes. A tool that opens the door still leaves someone to walk through it.
What It Means for You
If you or someone you love is in recovery, the takeaway is not to chase an experimental device. It is to stop accepting the framework that put the blame on character in the first place. Craving is a measurable brain state. It can be tracked, and increasingly it can be changed, which means recovery belongs in the hands of people who treat the brain as the organ it is. That is the whole premise of how we built Rescue From Rehab: start with the neurology, then do the human work on top of it, rather than the other way around.
The man in the scanner did not get a personality transplant. His brain got quieter, and for the first time in years he could hear himself think over the noise. That is what recovery has always been reaching for. We are finally getting tools precise enough to reach it directly.